Home › Markets › Industrials › UAN

CVR Partners LP Common Units representing Limited Partner Interests (UAN)

UAN trades on NYSE in Industrials, Agricultural Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$126.21
+0.57% on the day
Market cap
$1.3B
Small cap
Revenue · 2025
$606.0M
+15.4% on 2024
Net income · 2025
$98.7M
16.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerUAN on NYSE
SectorIndustrials
IndustryAgricultural Chemicals
CountryUnited States
IPO year2011
SEC CIK0001425292
SEC industry codeAgricultural Chemicals
Incorporated inDE

Financials · 2025

LineValue
Revenue$606.0M
Net income$98.7M
Operating income$128.7M
Net margin16.3%
Operating margin21.2%
Revenue growth+15.4%
Cash$69.2M
Total assets$969.5M
P/E (computed)13.5×
P/S (computed)2.2×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32025-10-31
Latest annual report10-K2026-02-18
Latest quarterly / interim10-Q2026-07-29
Latest current report8-K2026-07-29
Latest proxyDEFA14A2025-04-22

Source: SEC EDGAR submissions feed, 540 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.8%
1 month-5.2%
3 months+7.4%
Year to date+24.5%
1 year+38.2%
From 52-week high-8.2%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Agricultural Chemicals

TickerCompanyPriceDayMarket cap
SMGScotts Miracle-Gro Company (The)$50.10+0.32%$2.9B
MOSMosaic Company (The)$19.18+1.75%$6.1B
ICLICL Group Ltd.$4.98+0.81%$6.4B
CBUSCibus Inc.$1.41-4.73%$107.8M
CFCF Industries Holdings Inc.$117.25+2.33%$17.7B
NTRNutrien Ltd. Common Shares$69.68+2.47%$33.6B
AVDAmerican Vanguard Corporation Common Stock ($0.10 Par Value)$1.33-5.67%$39.2M
BIOXBioceres Crop Solutions Corp.$0.3250-1.81%$20.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier